These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 5154894)

  • 1. Product of Staphylococcus aureus responsible for the scalded-skin syndrome.
    Kapral FA; Miller MM
    Infect Immun; 1971 Nov; 4(5):541-5. PubMed ID: 5154894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of exfoliatin produced by Staphylococcus aureus of bacteriophage group 2 and its physicochemical properties.
    Kondo I; Sakurai S; Sarai Y
    Infect Immun; 1973 Aug; 8(2):156-64. PubMed ID: 4269383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New type of exfoliatin obtained from staphylococcal strains, belonging to phage groups other than group II, isolated from patients with impetigo and Ritter's disease.
    Kondo I; Sakurai S; Sarai Y
    Infect Immun; 1974 Oct; 10(4):851-61. PubMed ID: 4139120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the occurrence of protein A and some other properties in Staphylococcus aureus.
    Lind I
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(5):702-8. PubMed ID: 4264284
    [No Abstract]   [Full Text] [Related]  

  • 5. Two serotypes of exfoliatin and their distribution in staphylococcal strains isolated from patients with scalded skin syndrome.
    Kondo I; Sakurai S; Sarai Y; Futaki S
    J Clin Microbiol; 1975 May; 1(5):397-400. PubMed ID: 126250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcal scalded skin syndrome I. Purification of exfoliatin and maternal transmission of neutralizing ability against exfoliatin.
    Nishioka K; Nakano T; Hirao N; Asada Y
    J Dermatol; 1977 Feb; 4(1):13-8. PubMed ID: 16688917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcal scalded skin syndrome in two immunocompetent adults caused by exfoliatin B-producing Staphylococcus aureus.
    Opal SM; Johnson-Winegar AD; Cross AS
    J Clin Microbiol; 1988 Jul; 26(7):1283-6. PubMed ID: 3137245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of Staphylococcus aureus exfoliatin by antibody.
    Miller MM; Kapral FA
    Infect Immun; 1972 Oct; 6(4):561-3. PubMed ID: 4634954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of exfoliatin toxin A production by Staphylococcus aureus strains isolated from clustered epidemics of neonatal pustulosis.
    Kaplan MH; Chmel H; Hsieh HC; Stephens A; Brinsko V
    J Clin Microbiol; 1986 Jan; 23(1):83-91. PubMed ID: 3700612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurence of protein A in strains of Staphylococcus aureus demonstrated by means of labelled globulins.
    Lind I
    Contrib Microbiol Immunol; 1973; 1():93-7. PubMed ID: 4616795
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevalence of exfoliatin-producing strains in phage group II "Staphylococcus aureus" (author's transl)].
    Fleurette J; Ritter J
    Ann Microbiol (Paris); 1980; 131B(2):175-83. PubMed ID: 6450560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of an outbreak of staphylococcal scalded skin syndrome: strategies for typing 'non-typable' strains.
    Dowsett EG; Petts DN; Baker SL; DeSaxe MJ; Coe AE; Naidoo J; Noble WC
    J Hosp Infect; 1984 Dec; 5(4):391-7. PubMed ID: 6085094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fate of Staphylococcal exfoliatin in newborn and adult mice.
    Fritsch P; Elias P; Varga J
    Br J Dermatol; 1976 Sep; 95(3):275-84. PubMed ID: 974018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of 3 heterologous expression systems for obtaining recombinant Bacillus thuringiensis delta-endotoxins].
    Vázquez R; Prieto D; Olóriz MI; de la Riva GA; Selman-Housein G
    Rev Latinoam Microbiol; 1995; 37(3):237-44. PubMed ID: 8850342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized exfoliation associated with Staphylococcus aureus infection.
    Lynch JM; Dreiling R; Hodges GR; Huffman D; Dixon A; Barnes WG; Kapral FA
    South Med J; 1981 Jan; 74(1):24-7. PubMed ID: 7455736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcal scalded skin syndrome: potentiation by immunosuppression in mice; toxin-mediated exfoliation in a healthy adult.
    Wiley BB; Allman S; Rogolsky M; Norden CW; Glasgow LA
    Infect Immun; 1974 Apr; 9(4):636-40. PubMed ID: 4822864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ethidium bromide on elimination of exfoliative toxin and bacteriocin production in Staphylococcus aureus.
    Warren R; Rogolsky M; Wiley BB; Glasgow LA
    J Bacteriol; 1974 Jun; 118(3):980-5. PubMed ID: 4829933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyt1Ca from Bacillus thuringiensis subsp. israelensis: production in Escherichia coli and comparison of its biological activities with those of other Cyt-like proteins.
    Manasherob R; Itsko M; Sela-Baranes N; Ben-Dov E; Berry C; Cohen S; Zaritsky A
    Microbiology (Reading); 2006 Sep; 152(Pt 9):2651-2659. PubMed ID: 16946260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale production and characterization of Bacillus thuringiensis subsp. tenebrionis insecticidal protein from Escherichia coli.
    Gustafson ME; Clayton RA; Lavrik PB; Johnson GV; Leimgruber RM; Sims SR; Bartnicki DE
    Appl Microbiol Biotechnol; 1997 Mar; 47(3):255-61. PubMed ID: 9114517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity of protein A mutants of Staphylococcus aureus.
    Forsgren A
    Contrib Microbiol Immunol; 1973; 1():102-8. PubMed ID: 4376072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.